covid-19-vaccines

Documents about covid-19-vaccines

• Phase 3 Boosting Study for the SARS-CoV-2 rS Variant Vaccines#865847ClinicalTrials.gov
• Humoral and Cellular Immune Response to COVID-19 Vaccines in Immunocompromised and Healthy Individuals#873616ClinicalTrials.gov
• Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines#86678PhilArchive
• Investigating the effects and underlying mechanisms of glycosylation sites on the immunogenicity of COVID-19 vaccines.#186224NCBI PubMed Central
• Medicine-induced Cardiac Hemodialysis on COVID-19#226356ClinicalTrials.gov
• An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants#326299HAL (France)
• A novel lexicon dictionary and CNN-LSTM employed hybrid approach for sentiment detection of COVID-19 vaccines.#388800NCBI PubMed Central
• Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults#417575ClinicalTrials.gov
• Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.#823589NCBI PubMed Central
• Immunomodulatory Effect of Probiotics on the Immunogenicity of Anti-SARS-CoV-2 Vaccines#873439ClinicalTrials.gov
• Safety of COVID-19 and influenza vaccines in children and adolescents with immunocompromised or autoimmune conditions: Findings from the Canadian National Vaccine Safety (CANVAS) network#253548Europe PMC
• The CDC’s management and COVID-19 vaccine recommendations during the COVID-19 pandemic: A healthcare worker’s perspective#473123PLOS
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults#858520ClinicalTrials.gov
• Data for: COVID Diaries, Part II: U.S. Media Response to COVID Vaccination Program, December 2020 to September 2021#939421QDR Main Collection Dataverse OAI Archive
• Equitable access to the COVID-19 vaccines in Africa (ECOVA) findings from a qualitative enquiry in Zimbabwe.#13402NCBI PubMed Central
• Scoping review of COVID-19 vaccines access, equity, hesitancy, and uptake in Kenya: lessons for the next pandemic.#236219NCBI PubMed Central
• How Ought We Allocate Unanticipated Doses of COVID-19 Vaccines? A proposal based on experience in the United States, 2020-2022#705392PhilArchive
• An ethical analysis of the impact of covid-19 vaccine patents on the accessibility of vaccines in developing countries#456480WIReDSpace
• COVID-19 Vaccination among People Living with HIV: Immunogenicity, Effectiveness, and Safety [COVAXHIV, study data contributed to the CITF Databank]#633659Borealis Dataverse OAI Archive
• Data for: COVID Diaries, State Response to COVID Vaccination Program, December 2020 to September 2021#939491QDR Main Collection Dataverse OAI Archive
• Immunogenicity and Safety of Commercially Available Vaccines Against SARS-CoV-2 (COVID-19) in Patients With Hematologic Malignancies#903939ClinicalTrials.gov
• Perceptions About Influenza and COVID-19 Vaccines Among People With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.#193373NCBI PubMed Central
• COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines#866270ClinicalTrials.gov
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants#300317ClinicalTrials.gov
• A national cross-sectional study of dentists' vaccine hesitancy and intention to provide HPV vaccines following emergency COVID-19 vaccination authorization.#30716NCBI PubMed Central
• Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action#163569WIPO
• Using BCG to Protect Senior Citizens During the COVID-19 Pandemic#195379ClinicalTrials.gov
• Uptake of COVID-19 Vaccines and Intention to Vaccinate in the Democratic Republic of the Congo: A Cross-Sectional Survey.#423135NCBI PubMed Central
• Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults#633766ClinicalTrials.gov
• Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.#841781ClinicalTrials.gov
• Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda#405205ClinicalTrials.gov
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age#890407ClinicalTrials.gov
• A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers#981074ClinicalTrials.gov
• Does TRIPS (Agreement on Trade‐Related Aspects of Intellectual Property Rights) prevent COVID‐19 vaccines as a global public good?#163599WIPO
• Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication#883416ClinicalTrials.gov
• Covid-19 and influenza vaccine hesitancy insights from France, Italy and Hungary: A mixed-methods study.#9886PubMed
• Gaps Between Willingness and Uptake of Influenza and COVID-19 Vaccines During the 2025-26 Respiratory Virus Season in a U.S. Adult Cohort#459897bioRxiv / medRxiv
• Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate#824994ClinicalTrials.gov
• Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma#918450ClinicalTrials.gov
• A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).#902910ClinicalTrials.gov
• Monoclonal antibody levels and protection from COVID-19#201390UNSWorks Repository
• Receptor binding domain-independent pancoronavirus vaccine design by fusion of conserved T/B Epitopes.#9713PubMed
• Biochemical and demographic data for adult participants who received three doses of COVID-19 vaccines#205924IBISS
• Common Measures of Vaccination Intention Generate Substantially Different Estimates That Can Reduce Predictive Validity#313433Scholarly Commons at Boston University School of Law
• Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.#1010099ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age#268075ClinicalTrials.gov
• Replication Data for: Active vaccine safety surveillance in sub-Saharan Africa: Experience from a prospective cohort event monitoring study of COVID-19 vaccines in Kenya#348132LSHTM Data Compass
• The effectiveness of COVID-19 vaccines in Latin America, 2021 : a multicenter regional case–control study#228839Universidad Nacional de Hurlingham
• Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)#901891ClinicalTrials.gov
• Impact of COVID-19 Vaccines on Cerebrovascular Health#916525ClinicalTrials.gov